The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.
The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.
The Department of Health and Human Services (HHS) issued a statement on Sunday:
The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.
America Will Turn 250 in July as a Deeply Divided Country, But Our Spirit Remains Unbroken
Louisiana Passes Key Bill Letting Churches Protect Themselves from Leftist Protesters
The next frontier: Washington grapples with its latest space oddity
Soros-backed nonprofit accuses NJ Gov Sherrill of spreading ‘MAGA propaganda’ on ICE detainees
Taxpayer-funded ‘Meth Mansion’ under fire as crime concerns mount around homeless campus
Israeli soldier killed near Beaufort Castle, symbol of past occupation of Lebanon, as Trump demands ceasefire
Judge unseals DOJ fight with Fulton County over 2020 election worker information
Priceless Video: Living Wall of Riot Cops Opens, Pulls in Unsuspecting Anti-ICE Punk, Closes Like He Was Never There
Trump admin backs off controversial $2B fund, clearing path for stalled GOP immigration bill
Watch: MSNBC Shill Is Scared to Attend July 4 Parties but Was Somehow Fine When BLM Burned Down Minneapolis Behind Him
Teen athlete arrested, three horses pulled from competition after alleged overnight barn attack
Biden’s posh vacation enclave roiled as church axes July 4 tradition over ‘whiteness’ debate: ‘Spewing lies’
Judge denies Tyler Robinson secrecy request and orders hearing on prosecutors’ statements
Marine combat veteran bets big on Hispanic outreach in bid to flip Dem-held House seat
Video: Panicking Anti-ICE ‘Medic’ Is Almost in Tears Begging Rioters to Leave as NJ State Police Roll in the Big Guns
HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”
Earlier, the French government had approved similar drugs to treat the virus.
Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”
America Will Turn 250 in July as a Deeply Divided Country, But Our Spirit Remains Unbroken
Louisiana Passes Key Bill Letting Churches Protect Themselves from Leftist Protesters
The next frontier: Washington grapples with its latest space oddity
Soros-backed nonprofit accuses NJ Gov Sherrill of spreading ‘MAGA propaganda’ on ICE detainees
Taxpayer-funded ‘Meth Mansion’ under fire as crime concerns mount around homeless campus
Israeli soldier killed near Beaufort Castle, symbol of past occupation of Lebanon, as Trump demands ceasefire
Judge unseals DOJ fight with Fulton County over 2020 election worker information
Priceless Video: Living Wall of Riot Cops Opens, Pulls in Unsuspecting Anti-ICE Punk, Closes Like He Was Never There
Trump admin backs off controversial $2B fund, clearing path for stalled GOP immigration bill
Watch: MSNBC Shill Is Scared to Attend July 4 Parties but Was Somehow Fine When BLM Burned Down Minneapolis Behind Him
Teen athlete arrested, three horses pulled from competition after alleged overnight barn attack
Biden’s posh vacation enclave roiled as church axes July 4 tradition over ‘whiteness’ debate: ‘Spewing lies’
Judge denies Tyler Robinson secrecy request and orders hearing on prosecutors’ statements
Marine combat veteran bets big on Hispanic outreach in bid to flip Dem-held House seat
Video: Panicking Anti-ICE ‘Medic’ Is Almost in Tears Begging Rioters to Leave as NJ State Police Roll in the Big Guns
President Donald Trump has suggested that hydroxychloroquine could be effective, and has encouraged further study. His interest in the drug has prompted pushback from the media.
NBC News’ Peter Alexander accused the president last week of giving Americans “false hope,” and Politico’s Dan Diamond reported Sunday that the FDA decision came despite “scant evidence,” adding that “[c]areer scientists have been skeptical of the effort.”
Story cited here.
